nti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
Wardrop D., Estcourt L., Doree C., Hopewell S., Brunskill SJ., Stanworth S., Murphy MF.
This is the protocol for a review and there is no abstract. The objectives are as follows:To determine the efficacy and safety of anti-fibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders.